top of page
Principal Scientist

Sai Velagapudi, PhD

Senior Scientist

Associate Scientist

Nicole DeLorenzo, BS

Senior Scientist

Associate Scientist

Michelle Arsenault, BS

Senior Scientist

Scientist

Kamal Vishnu, MS

Senior Scientist

Research Associate II

Treleasha Simmons, BS

Senior Scientist

Research Associate II

Jason Ilardo

Senior Scientist

Senior Scientist II

Alicia Angelbello, PhD

Senior Scientist

Principal Scientist

Helen Crehan, PhD

Senior Scientist

Associate Scientist

Van Ha, MS

Senior Scientist

Senior Scientist I

Jared Baisden, PhD

Senior Scientist

Scientific Program Manager

Virginia Smith, PhD

Senior Scientist

Research Associate I

Daniela Saldias, BS

Senior Scientist

Senior Scientist I

Shrikant Sharma, PhD

Senior Scientist

Research Associate I

Toni-Ann Martorano, MS

Senior Scientist

Associate Director, Operations

Sandra Mueller

Senior Scientist

...and the many Expanding the vision to cure mRNA mediated diseases.  

RNA and the World of Small Molecules

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases

Board of Directors

Scientific Advisory Board

Scott M. Rocklage, PhD

Board Chairman

Andy Phillips, PhD

Board Director

Beth Seidenberg, MD

Board Director

Renato Skerlj, PhD

Board Director

Laura Tadvalkar, PhD

Board Director

Gary J. Bridger, PhD

Board Director

Raymond Kelleher, MD, PhD

Board Director

Matthew Disney, PhD

Scientific Founder, Scientific Advisory Board Chair,
Professor, UF Scripps Research

Robert T. Batey, PhD

Professor, University of Colorado

Kenneth S. Kosik, M.D.

Professor, University of California

M.G. Finn, PhD

Professor, Georgia Institute of Technology

Melissa A. Starovasnik, PhD

Scientific Leader

Lynne E. Maquat, PhD

Chair and Professor, University of Rochester

Leonard Petrucelli, PhD

Professor, Mayo Clinic College of Medicine and Science

INVESTORS

Expansion Leadership

We believe that the development of small molecule drugs that modulate RNA will dramatically  change patient outcomes for diseases where treatment options for patients are currently limited

Mark Ledeboer, PhD

Senior VP, Drug Discovery

Valerie Cullen, PhD

Senior VP, Research

Renato Skerlj, PhD

President & CEO

Andrew Good, PhD

VP, Computational Chemistry

Jennifer Visco, CPA

VP, Finance & Business Operations

Peter Connolly, PhD

Senior Director, Structural Biology

Suzanne Rzuczek, PhD

Associate Director, Biology

We are a team in relentless pursuit of game changing solutions in human health 

Our team's work is founded upon leading research emerging from Scripps Research

Our management team has deep experience in bringing life-changing drugs from bench to clinic and ultimately to market

Drug Hunters

Success Record

Inspired Research

Sai Velagadupi, PhD

Senior Scientist

Nicole DeLorenzo

Sr. Research Associate

Michelle House

Sr. Research Associate

Kamalakannan Vishnu

Associate Scientist

Jennifer Todesca

Operations Manager,

Executive Assistant to CEO

Treleasha Simmons

Research Associate

Jason-Ilardo

Research Assistant

Abe Silfen

Lab Operations Associate

Alicia Angelbello, PhD

Scientist, Biology

Tiviane Vu

Associate Director,

Project Management

Van Ha

Associate Scientist

bottom of page